lobbying_activities: 2638317

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2638317	c8e18b69-4445-4828-a172-4cabcf01114d	Q2	STRATEGIC MARKETING INNOVATIONS	60550	IGM BIOSCIENCES, INC.	2021	second_quarter	MED	Antibody therapy for COVID-19	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2021-07-15T15:00:55.590000-04:00